Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Daiichi Sankyo secures FDA approval for Turalio to treat TGCT patients

pharmaceutical-technologyAugust 06, 2019

Tag: FDA , Daiichi Sankyo , Turalio

PharmaSources Customer Service